Kanarek-Kucner Joanna, Stefański Adrian, Barraclough Rufus, Gorycki Tomasz, Wolf Jacek, Narkiewicz Krzysztof, Hoffmann Michał
a Department of Hypertension and Diabetology, Faculty of Medicine , Medical University of Gdansk , Gdansk , Poland.
b Department of Radiology, Faculty of Medicine , Medical University of Gdansk , Gdansk , Poland.
Blood Press. 2018 Oct;27(5):304-312. doi: 10.1080/08037051.2018.1470460. Epub 2018 May 9.
Primary aldosteronism (PA) is the most common cause of secondary hypertension and bilateral adrenal hyperplasia (BAH) and aldosterone-producing adenoma (APA) seem to be the most common causes of PA. Unilateral adrenalectomy (UA) is the preferred treatment for APA, although the benefits are still difficult to assess.
We present a case report of a 69-year old man with a 30 year history of hypertension and probably long-standing PA due to APA, with typical organ complications. Since repeated abdominal CT scans were equivocal, not showing radiological changes characteristic for PA, the diagnosis of APA was delayed and was only finally confirmed by adrenal venous sampling which demonstrated unilateral aldosteronism. The patient underwent UA, complicated by mineralocorticoid deficiency syndrome and increased creatinine and potassium levels. At 12 months follow-up the patient still had hyperkalemia and was fludrocortisone dependent.
Older patients and patients with long-lasting PA who are treated with UA may demonstrate deterioration of renal function and develop transient or persistent insufficiency of the zona glomerulosa of the remaining adrenal gland necessitating fludrocortisone supplementation. Transient hyperkalemia may be observed following UA as a result of the prolonged effects of aldosterone antagonists and/or transient mineralocorticoid/glucocorticoid insufficiency. Additionally, the level of progression of chronic kidney disease after UA is difficult to predict. There likely exists a group of patients who might paradoxically have higher cardiovascular risk due to significant deterioration in kidney function not only resulting from the removal of the aldosterone induced glomerular hyperfiltration phenomenon. Identification of such a group requires further detailed investigation.
原发性醛固酮增多症(PA)是继发性高血压最常见的病因,双侧肾上腺增生(BAH)和醛固酮瘤(APA)似乎是PA最常见的病因。单侧肾上腺切除术(UA)是APA的首选治疗方法,尽管其益处仍难以评估。
我们报告一例69岁男性患者,有30年高血压病史,可能因APA导致长期PA,并伴有典型的器官并发症。由于多次腹部CT扫描结果不明确,未显示PA的典型影像学改变,APA的诊断被延迟,最终通过肾上腺静脉采血证实为单侧醛固酮增多症才得以确诊。该患者接受了UA治疗,并发盐皮质激素缺乏综合征,肌酐和钾水平升高。随访12个月时,患者仍有高钾血症,且依赖氟氢可的松。
接受UA治疗的老年患者和长期PA患者可能会出现肾功能恶化,并出现剩余肾上腺球状带短暂或持续的功能不全,需要补充氟氢可的松。UA后可能会观察到短暂性高钾血症,这是由于醛固酮拮抗剂的长期作用和/或短暂性盐皮质激素/糖皮质激素不足所致。此外,UA后慢性肾脏病的进展程度难以预测。可能存在一组患者,由于肾功能显著恶化,不仅是因为去除了醛固酮诱导的肾小球高滤过现象,反而可能具有更高的心血管风险。识别这样一组患者需要进一步详细研究。